Apr 19,2021

Insulet Announces Launch of Syndication of New Credit Facilities

The closing of the senior secured credit facilities and the terms thereof are subject to obtaining lender commitments, as well as market and other conditions. Insulet intends to use the proceeds of the senior secured credit facilities for general corporate purposes, including to retire indebtedness and/or to fund investments.

View Analyst & Ambassador Comments
Go to original news
Apr 19,2021

Diabetes Reversal Leader Virta Health Raises $133M Series E to Take Type 2 Diabetes Reversal Mainstream

Led by Tiger Global, the financing values Virta at $2 billion and signals a shift in type 2 diabetes care toward long-term disease reversal powered by next-generation telehealth

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Apr 20,2021

ABBOTT REPORTS FIRST-QUARTER 2021 RESULTS

First-quarter sales of $10.5 billion increased 35.3 percent on a reported basis and 32.9 percent on an organic basis, which excludes the impact of foreign exchange.

View Analyst & Ambassador Comments
Go to original news
Apr 21,2021

DIAMONTECH RECEIVES OFFICIAL QMS CERTIFICATION (ISO13485:2016)

ISO 13485:2016 sets out the requirements for a comprehensive quality management system for the development and manufacture of medical devices, thereby ensuring the safety and effectiveness of the products.

PRODUCT

#bgm

View Analyst & Ambassador Comments
Go to original news
Apr 21,2021

Fitterfly raises $3.1 million in funding round led by Fireside Ventures

Fireside Ventures, which is making its first healthtech bet in Fitterfly, will get a significant stake as well as a board seat for Managing Partner Kanwaljit Singh in the two-year-old startup. Read more at: https://economictimes.indiatimes.com/tech/funding/fitterfly-raises-3-1-million-in-funding-round-led-by-fireside-ventures/articleshow/82162628.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 26,2021

Teladoc Health Names Technology Leader Claus Jensen as Chief Innovation Officer

Teledoc Health has named Claus Jensen as chief innovation officer to lead the research and development team

View Analyst & Ambassador Comments
Go to original news
Apr 26,2021

BD Announces FDA 510(k) Submission for BD Alaris™ System

The 510(k) submission is intended to bring the regulatory clearance for the BD Alaris™ System up to date, implement updated features and address open recall issues, including through a new version of BD Alaris™ System software that will provide clinical, operational and cybersecurity updates.

REGULATORY FDA

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Apr 27,2021

BD Board Declares Dividend

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, payable on June 30, 2021 to holders of record on June 9, 2021....

View Analyst & Ambassador Comments
Go to original news
Apr 27,2021

Voluntis and Eisai to collaborate on digital therapeutics for oncology patients

Collaboration and license agreement to develop digital therapeutics based on Theraxium and supporting cancer treatment

COLLABORATION Removed1_PARTNERSHIP

#product & service

#dtx

View Analyst & Ambassador Comments
Go to original news
Apr 28,2021

Welldoc Granted 20th US Patent, Growing Company’s Platform Solutions

Columbia, MD – April 28, 2021 — Welldoc®, a trailblazer in digital health that is revolutionizing chronic condition management to help transform lives, today announced that the company’s 20th U.S. patent was granted …

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES